Comparison of Hypoxia-inducible Factor-1α Expression before and after Transcatheter Arterial Embolization in Rabbit VX2 Liver Tumors

Journal of Vascular and Interventional Radiology

Volumn 19, Issue 10, 2008, Pages 1483-1489

  Virmani, Sumeet ^a   Rhee, Thomas K ^a   Ryu, Robert K ^a   Sato, Kent T ^a   Lewandowski, Robert J ^a   Mulcahy, Mary F ^a   Kulik, Laura M ^a   Szolc Kowalska, Barbara ^a   Woloschak, Gayle E ^a   Yang, Guang Yu ^a   Salem, Riad ^a   Larson, Andrew C ^a,b   Omary, Reed A ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Northwestern University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1ALPHA ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL EMBOLISM; CONTROLLED STUDY; ECHOGRAPHY; HYPOXIA; LIVER TUMOR; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; TUMOR BIOPSY; WILCOXON SIGNED RANKS TEST;

ANIMALS; CATHETERIZATION, PERIPHERAL; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; EMBOLIZATION, THERAPEUTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LIVER NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; RABBITS;

EID: 52149116938     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2008.06.017     Document Type: Article

References (20)

1. Llovet J.M. Updated treatment approach to hepatocellular carcinoma. J Gastroenterol 40 (2005) 225-235
2. Llovet J.M., Schwartz M., and Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 25 (2005) 181-200
3. Llovet J.M., and Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37 (2003) 429-442
4. Liao X.F., Yi J.L., Li X.R., Deng W., Yang Z.F., and Tian G. Angiogenesis in rabbit hepatic tumor after transcatheter arterial embolization. World J Gastroenterol 10 (2004) 1885-1889
5. Seki T., Tamai T., Ikeda K., et al. Rapid progression of hepatocellular carcinoma after transcatheter arterial chemoembolization and percutaneous radiofrequency ablation in the primary tumour region. Eur J Gastroenterol Hepatol 13 (2001) 291-294
6. Kim K.R., Moon H.E., and Kim K.W. Hypoxia-induced angiogenesis in human hepatocellular carcinoma. J Mol Med 80 (2002) 703-714
7. Wu X.Z., Xie G.R., and Chen D. Hypoxia and hepatocellular carcinoma: the therapeutic target for hepatocellular carcinoma. J Gastroenterol Hepatol 22 (2007) 1178-1182
8. Semenza G.L., and Wang G.L. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 12 (1992) 5447-5454
9. Sun H.C., and Tang Z.Y. Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectives. J Cancer Res Clin Oncol 130 (2004) 307-319
10. Bozova S., and Elpek G.O. Hypoxia-inducible factor-1alpha expression in experimental cirrhosis: correlation with vascular endothelial growth factor expression and angiogenesis. APMIS 115 (2007) 795-801
11. Rhee T.K., Young J.Y., Larson A.C., et al. Effect of transcatheter arterial embolization on levels of hypoxia-inducible factor-1α in rabbit VX2 liver tumors. J Vasc Interv Radiol 18 (2007) 639-645
12. Virmani S., Wang D., Harris K.R., et al. Comparison of transcatheter intraarterial perfusion MR imaging and fluorescent microsphere perfusion measurements during transcatheter arterial embolization of rabbit liver tumors. J Vasc Interv Radiol 18 (2007) 1280-1286
13. Virmani S., Harris K.R., Szolc-Kowalska B., et al. Comparison of two different methods for inoculating VX2 tumors in rabbit livers and hind limbs. J Vasc Interv Radiol 19 (2008) 931-936
14. Laurent A., Wassef M., Chapot R., et al. Partition of calibrated tris-acryl gelatin microspheres in the arterial vasculature of embolized nasopharyngeal angiofibromas and paragangliomas. J Vasc Interv Radiol 16 (2005) 507-513
15. Lewandowski R.J., Wang D., Gehl J., et al. A comparison of chemoembolization endpoints using angiographic versus transcatheter intraarterial perfusion/MR imaging monitoring. J Vasc Interv Radiol 18 (2007) 1249-1257
16. Huang G.W., Yang L.Y., and Lu W.Q. Expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in hepatocellular carcinoma: Impact on neovascularization and survival. World J Gastroenterol 11 (2005) 1705-1708
17. Talks K.L., Turley H., Gatter K.C., et al. The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol 157 (2000) 411-421
18. Zhong H., De Marzo A.M., Laughner E., et al. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 59 (1999) 5830-5835
19. Huang L.E., Gu J., Schau M., and Bunn H.F. Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci U S A 95 (1998) 7987-7992
20. Jewell U.R., Kvietikova I., Scheid A., Bauer C., Wenger R.H., and Gassmann M. Induction of HIF-1alpha in response to hypoxia is instantaneous. Faseb J 15 (2001) 1312-1314